Pharmafile Logo
Pharmafocus logo
Advanced Search
minaris-mg_7425-web

MaxiVAX and Minaris sign manufacturing deal for cell-based cancer immunotherapy

February 22, 2021
Sales and Marketing Cancer, MaxiVAX, Minaris

MaxiVAX and Minaris Regenerative Medicine have entered into a manufacturing agreement for MVX-ONCO-2, a cell-based immunotherapy for the treatment of …

News
astrazeneca_plaque

AstraZeneca to withdraw Imfinzi US indication for bladder cancer

February 22, 2021
Sales and Marketing AstraZeneca, Imfinzi

AstraZeneca will voluntarily withdraw the Imfinzi (durvalumab) indication in the US for previously treated adult patients with locally advanced or …

News
tukysa

Seagen’s breast cancer drug TUKYSA gets UK approval

February 22, 2021
Sales and Marketing Cancer, MHRA, Seagen

The MHRA has granted marketing authorisation in the UK for Seagen’s TUKYSA (tucatinib) in combination with trastuzumab and capecitabine, for …

News
top 10

Pharmafile.com’s top 10 news stories of the week

February 19, 2021
Medical Communications COVID-19, COVID-19 vaccine, Vaccine, pharma news, top 10, top news stories

In the last week, a number of COVID-19 new vaccine developments have been made. Pfizer and BioNTech’s vaccine has proven …

News

New Cell Guidance technology has potential to help treat cancer

February 19, 2021
Medical Communications Cancer, cancer treatment, cell guidance systems, macrophages, pharma news

Cell Guidance Systems’ new POlyhedrin Delivery System (PODS) technology has been shown to have therapeutic potential in the treatment of …

News
cascade_chemistry_new_facility_rendering_highres

Cascade Chemistry begins $14m manufacturing facility expansion

February 19, 2021
Medical Communications Cascade Chemistry, manufacturing

Cascade Chemistry, a leading pharmaceutical contract development and manufacturing organisation, has initiated the $14 million construction of new facilities to …

News
cream-4713579_1920

Dermavant announces positive Phase III findings for psoriasis treatment tapinarof

February 19, 2021
Medical Communications Dermavant Sciences, psoriasis

Dermavant Sciences has announced positive safety and efficacy results from a planned interim analysis of PSOARING 3, a long-term, open-label …

News

RedHill enters manufacturing deal with Cosmo for two key products

February 19, 2021
Medical Communications RedHill Biopharma

RedHill Biopharma has announced agreements with Cosmo Pharmaceuticals to manufacture two of RedHill’s key products. Cosmo will manufacture Movantik, RedHill’s …

News

Onward and Biomunex agree deal to collaborate on cancer treatment

February 18, 2021

Onward Therapeutics and Biomunex Pharmaceuticals have signed a co-development agreement of a bi-specific antibody for cancer patients.

News
nektar-therapeutics

Nektar and SFJ collaborate to develop experimental head and neck cancer drug

February 18, 2021
Cancer, Nektar Therapeutics

Nektar Therapeutics has announced a financing and co-development collaboration with SFJ Pharmaceuticals to support the development of Bempegaldesleukin (BEMPEG), an investigational CD122-preferential …

News
glaxosmithkline building

GSK and Vir agree deal worth $645m for influenza and respiratory treatments

February 18, 2021
GSK, Vaccine, flu, influenze, vir

GSK and Vir Biotechnology have extended their collaboration in a deal that could be worth up to $645 million, in …

News
almirall-605x338

MC2 Therapeutics grants Almirall European commercial rights for psoriasis cream Wynzora

February 18, 2021
Almirall, MC2 Therapeutics, psoriasis

Biopharma company Almirall and MC2 Therapeutics, a pharmaceutical company focused on therapies for autoimmune and chronic inflammatory conditions, have announced …

News
lilly_entrance_web

Eli Lilly’s diabetes drug tirzepatide reduces blood glucose and weight in Phase III trials

February 18, 2021
Eli Lilly, diabetes

Eli Lilly’s tirzepatide led to significant haemoglobin A1C (HbA1C) and body weight reductions from baseline in adults with type 2 …

News
covid-19 virus

Pharmafile.com’s weekly COVID-19 news round-up

February 17, 2021
Research and Development COVID-19, COVID-19 vaccine, Vaccine, World Health Organisation, covid-19 roundup

The past week has continued to see positive COVID-19 vaccine news; a WHO panel approved the Oxford-AstraZeneca vaccine for all …

News

J&J’s one-shot COVID-19 vaccine submitted to the EU

February 17, 2021
Research and Development COVID, COVID Vaccine, COVID-19, Johnson & Johnson, Vaccine

Johnson & Johnson has applied to the EMA for marketing authorisation of their one-shot COVID-19 vaccine in Europe.

News
lynparza

AstraZeneca and MSD’s Lynparza crosses superiority boundary for invasive disease-free survival

February 17, 2021
Research and Development AstraZeneca, Cancer, MSD

The OlympiA Phase III trial for AstraZeneca and MSD’s cancer drug Lynparza will move to early primary analysis and reporting, …

News

Novartis and Gates Foundation join forces on sickle cell disease research

February 17, 2021
Research and Development Novartis, sickle cell disease

Novartis has entered into a grant agreement with the Bill & Melinda Gates Foundation, under which the foundation will fund …

News

FDA approves Novartis’ heart failure drug Entresto

February 17, 2021
Research and Development FDA, Novartis

The FDA has approved Novartis’ Entresto (sacubitril/valsartan) to reduce the risk of cardiovascular death and hospitalisation for heart failure in …

News

North Korea accused of attempted Pfizer hack to steal COVID-19 vaccine data

February 16, 2021
Manufacturing and Production COVID, COVID Vaccine, COVID-19, North Korea, Pfizer, Pfizer vaccine, Vaccine

North Korea has tried to hack into Pfizer’s servers in order to ascertain its COVID-19 vaccine technology, according to a …

News

South Korea orders 46 million more Novavax and Pfizer COVID-19 vaccines

February 16, 2021
Manufacturing and Production COVID, COVID-19, Novavax, Pfizer, Vaccine, south korea

South Korea has arranged deals with Novavax and Pfizer-BioNTech to buy enough COVID-19 vaccines for 23 million more people.

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026